Open AccessIncreased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
Author(s) -
Qunying Han,
Huan Deng,
Xiude Fan,
Xiaoyun Wang,
Xiaoge Zhang,
Kun Zhang,
Na Li,
Yi Lv,
Zhengwen Liu
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s337936
Subject(s) - hepatocellular carcinoma , medicine , ptx3 , hazard ratio , gastroenterology , hepatitis b virus , confidence interval , biomarker , hepatitis b , cirrhosis , proportional hazards model , immunology , virus , inflammation , biochemistry , chemistry
Hepatocellular carcinoma (HCC) is a major cause of liver-related mortality. Serum pentraxin 3 (PTX3) has been revealed to be associated with the development of hepatitis B virus (HBV)-related HCC. This study evaluated whether serum PTX3 is related to the survival of HBV-related HCC patients.